Works matching AU Sehouli, Jalid


Results: 269
    1
    2
    3
    4
    5
    6

    Management of malignant dysgerminoma of the ovary.

    Published in:
    European Journal of Gynaecological Oncology, 2022, v. 43, n. 2, p. 353, doi. 10.31083/j.ejgo4302041
    By:
    • Arndt, Tjadina;
    • Tabea Taube, Eliane;
    • Deubzer, Hedwig E.;
    • Rothe, Karin;
    • Calaminus, Gabriele;
    • Sehouli, Jalid;
    • Pietzner, Klaus
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

    Published in:
    2013
    By:
    • Bachmayr-Heyda, Anna;
    • Aust, Stefanie;
    • Heinze, Georg;
    • Polterauer, Stephan;
    • Grimm, Christoph;
    • Braicu, Elena Ioana;
    • Sehouli, Jalid;
    • Lambrechts, Sandrina;
    • Vergote, Ignace;
    • Mahner, Sven;
    • Pils, Dietmar;
    • Schuster, Eva;
    • Thalhammer, Theresia;
    • Horvat, Reinhard;
    • Denkert, Carsten;
    • Zeillinger, Robert;
    • Castillo-Tong, Dan Cacsire
    Publication type:
    journal article
    15

    A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-178
    By:
    • Pils, Dietmar;
    • Tong, Dan;
    • Hager, Gudrun;
    • Obermayr, Eva;
    • Aust, Stefanie;
    • Heinze, Georg;
    • Kohl, Maria;
    • Schuster, Eva;
    • Wolf, Andrea;
    • Sehouli, Jalid;
    • Braicu, Ioana;
    • Vergote, Ignace;
    • Van Gorp, Toon;
    • Mahner, Sven;
    • Concin, Nicole;
    • Speiser, Paul;
    • Zeillinger, Robert
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7637, doi. 10.1007/s00432-023-04647-9
    By:
    • Chekerov, Radoslav;
    • Arndt, Tjadina;
    • Pietzner, Klaus;
    • Canzler, Ulrich;
    • Wimberger, Pauline;
    • Strauß, Hans-Georg;
    • Mahner, Sven;
    • Woelber, Linn;
    • de Gregorio, Nikolaus;
    • Stocker, Gertraud;
    • von Abel, Ekkehard;
    • Neunhoeffer, Tanja;
    • Belau, Antje Kristina;
    • Mustea, Alexander;
    • Yalinkaya, Isil;
    • Braicu, Elena Ioana;
    • Richter, Rolf;
    • Sehouli, Jalid
    Publication type:
    Article
    23

    Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2523, doi. 10.1007/s00432-022-04101-2
    By:
    • Marchenko, Sofya;
    • Piwonski, Iris;
    • Hoffmann, Inga;
    • Sinn, Bruno Valentin;
    • Kunze, Catarina Alisa;
    • Monjé, Nanna;
    • Pohl, Jonathan;
    • Kulbe, Hagen;
    • Schmitt, Wolfgang Daniel;
    • Darb-Esfahani, Sylvia;
    • Braicu, Elena Ioana;
    • von Brünneck, Ann-Christin;
    • Sehouli, Jalid;
    • Denkert, Carsten;
    • Horst, David;
    • Jöhrens, Korinna;
    • Taube, Eliane Tabea
    Publication type:
    Article
    24

    Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1063, doi. 10.1007/s00432-019-02877-4
    By:
    • Guan, Jun;
    • Darb-Esfahani, Silvia;
    • Richter, Rolf;
    • Taube, Eliane T.;
    • Ruscito, Ilary;
    • Mahner, Sven;
    • Woelber, Linn;
    • Prieske, Katharina;
    • Concin, Nicole;
    • Vergote, Ignace;
    • Van Nieuwenhuysen, Els;
    • Achimas-Cadariu, Patriciu;
    • Glajzer, Joanna;
    • Woopen, Hannah;
    • Stanske, Mandy;
    • Kulbe, Hagen;
    • Denkert, Carsten;
    • Sehouli, Jalid;
    • Braicu, Elena Ioana
    Publication type:
    Article
    25
    26

    A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 3, p. 541, doi. 10.1007/s00432-016-2307-0
    By:
    • Sehouli, Jalid;
    • Tomè, Oliver;
    • Dimitrova, Desislava;
    • Camara, Oumar;
    • Runnebaum, Ingo;
    • Tessen, Hans;
    • Rautenberg, Beate;
    • Chekerov, Radoslav;
    • Muallem, Mustafa;
    • Lux, Michael;
    • Trarbach, Tanja;
    • Gitsch, Gerald
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Expression of classical NF-κB pathway effectors in human ovarian carcinoma.

    Published in:
    Histopathology, 2010, v. 56, n. 6, p. 727, doi. 10.1111/j.1365-2559.2010.03544.x
    By:
    • Darb-Esfahani, Silvia;
    • Sinn, Bruno V.;
    • Weichert, Wilko;
    • Budczies, Jan;
    • Lehmann, Annika;
    • Noske, Aurelia;
    • Buckendahl, Ann-Christin;
    • Müller, Berit Maria;
    • Sehouli, Jalid;
    • Koensgen, Dominique;
    • Györffy, Balazs;
    • Dietel, Manfred;
    • Denkert, Carsten
    Publication type:
    Article
    33
    34

    miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.

    Published in:
    Carcinogenesis, 2020, v. 41, n. 4, p. 442, doi. 10.1093/carcin/bgz163
    By:
    • Panoutsopoulou, Konstantina;
    • Avgeris, Margaritis;
    • Mavridis, Konstantinos;
    • Dreyer, Tobias;
    • Dorn, Julia;
    • Obermayr, Eva;
    • Reinthaller, Alexander;
    • Michaelidou, Kleita;
    • Mahner, Sven;
    • Vergote, Ignace;
    • Vanderstichele, Adriaan;
    • Braicu, Ioana;
    • Sehouli, Jalid;
    • Zeillinger, Robert;
    • Magdolen, Viktor;
    • Scorilas, Andreas
    Publication type:
    Article
    35
    36
    37
    38

    Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma.

    Published in:
    PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0116977
    By:
    • Okamoto, Aikou;
    • Sehouli, Jalid;
    • Yanaihara, Nozomu;
    • Hirata, Yukihiro;
    • Braicu, Ioana;
    • Kim, Byoung-Gie;
    • Takakura, Satoshi;
    • Saito, Misato;
    • Yanagida, Satoshi;
    • Takenaka, Masataka;
    • Yamaguchi, Noriko;
    • Morikawa, Asuka;
    • Tanabe, Hiroshi;
    • Yamada, Kyosuke;
    • Yoshihara, Kosuke;
    • Enomoto, Takayuki;
    • Itamochi, Hiroaki;
    • Kigawa, Junzo;
    • Matsumura, Noriomi;
    • Konishi, Ikuo
    Publication type:
    Article
    39
    40

    Methylation status of TUSC3 is a prognostic factor in ovarian cancer.

    Published in:
    2013
    By:
    • Pils, Dietmar;
    • Horak, Peter;
    • Vanhara, Petr;
    • Anees, Mariam;
    • Petz, Michaela;
    • Alfanz, Angela;
    • Gugerell, Alfred;
    • Wittinger, Michael;
    • Gleiss, Andreas;
    • Auner, Veronika;
    • Tong, Dan;
    • Zeillinger, Robert;
    • Braicu, Elena-Ioana;
    • Sehouli, Jalid;
    • Krainer, Michael
    Publication type:
    journal article
    41

    Methylation status of TUSC3 is a prognostic factor in ovarian cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 5, p. 946, doi. 10.1002/cncr.27850
    By:
    • Pils, Dietmar;
    • Horak, Peter;
    • Vanhara, Petr;
    • Anees, Mariam;
    • Petz, Michaela;
    • Alfanz, Angela;
    • Gugerell, Alfred;
    • Wittinger, Michael;
    • Gleiss, Andreas;
    • Auner, Veronika;
    • Tong, Dan;
    • Zeillinger, Robert;
    • Braicu, Elena‐Ioana;
    • Sehouli, Jalid;
    • Krainer, Michael
    Publication type:
    Article
    42
    43
    44
    45
    46

    Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer.

    Published in:
    Oncology, 2006, v. 70, n. 2, p. 141, doi. 10.1159/000093005
    By:
    • Al-Batran, Salah-Eddin;
    • Meerpohl, Hans-Gerd;
    • Von Minckwitz, Gunter;
    • Atmaca, Akin;
    • Kleeberg, Ulrich;
    • Harbeck, Nadia;
    • Lerbs, Werner;
    • Hecker, Detlef;
    • Sehouli, Jalid;
    • Knuth, Alexander;
    • Jager, Elke
    Publication type:
    Article
    47
    48

    Adjuvant Therapy in Lymph Node--Positive Vulvar Cancer: The AGO-CaRE-1 Study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju426
    By:
    • Mahner, Sven;
    • Jueckstock, Julia;
    • Hilpert, Felix;
    • Neuser, Petra;
    • Harter, Philipp;
    • de Gregorio, Nikolaus;
    • Hasenburg, Annette;
    • Sehouli, Jalid;
    • Habermann, Annika;
    • Hillemanns, Peter;
    • Fuerst, Sophie;
    • Strauss, Hans-Georg;
    • Baumann, Klaus;
    • Thiel, Falk;
    • Mustea, Alexander;
    • Meier, Werner;
    • du Bois, Andreas;
    • Griebel, Lis-Femke;
    • Woelber, Linn
    Publication type:
    Article
    49

    Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

    Published in:
    2015
    By:
    • Mahner, Sven;
    • Jueckstock, Julia;
    • Hilpert, Felix;
    • Neuser, Petra;
    • Harter, Philipp;
    • de Gregorio, Nikolaus;
    • Hasenburg, Annette;
    • Sehouli, Jalid;
    • Habermann, Annika;
    • Hillemanns, Peter;
    • Fuerst, Sophie;
    • Strauss, Hans-Georg;
    • Baumann, Klaus;
    • Thiel, Falk;
    • Mustea, Alexander;
    • Meier, Werner;
    • du Bois, Andreas;
    • Griebel, Lis-Femke;
    • Woelber, Linn;
    • AGO-CaRE 1 investigators
    Publication type:
    journal article
    50